Scientific Poster , Modified Release , Formulation Development

Development of modified release matrix tablet formulation using solid lipid Compritol 888 for a poorly water soluble drug

22 December 2021

Drug X is a poorly water soluble BCS/DCS II small molecule drug. In order to reduce the Cmax related side effects observed from the immediate release formulation, development of a modified release tablet was required.

22 December 2021